80_FR_23885 80 FR 23803 - Addressing Inadequate Information on Important Health Factors in Pharmacoepidemiology Studies Relying on Healthcare Databases; Public Workshop; Correction

80 FR 23803 - Addressing Inadequate Information on Important Health Factors in Pharmacoepidemiology Studies Relying on Healthcare Databases; Public Workshop; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 82 (April 29, 2015)

Page Range23803-23803
FR Document2015-09966

The Food and Drug Administration is correcting a notice entitled ``Addressing Inadequate Information on Important Health Factors in Pharmacoepidemiology Studies Relying on Healthcare Databases; Public Workshop'' that appeared in the Federal Register of April 17, 2015 (80 FR 21248). The document announced a public workshop. The document was published with the incorrect title. This document corrects that error.

Federal Register, Volume 80 Issue 82 (Wednesday, April 29, 2015)
[Federal Register Volume 80, Number 82 (Wednesday, April 29, 2015)]
[Notices]
[Page 23803]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-09966]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0001]


Addressing Inadequate Information on Important Health Factors in 
Pharmacoepidemiology Studies Relying on Healthcare Databases; Public 
Workshop; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a notice 
entitled ``Addressing Inadequate Information on Important Health 
Factors in Pharmacoepidemiology Studies Relying on Healthcare 
Databases; Public Workshop'' that appeared in the Federal Register of 
April 17, 2015 (80 FR 21248). The document announced a public workshop. 
The document was published with the incorrect title. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: Leslie Wheelock, Office of the 
Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 1, Rm. 4345, Silver Spring, MD, 301-796-8450, FAX: 301-847-8106, 
[email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of April 17, 2015, 
in FR Doc. 2015-08846, on page 21248 the following correction(s) is/are 
made:
    1. On page 21248, in the second column, starting at the sixth 
sentence of the first paragraph, the title ``Methodological 
Considerations to Address Unmeasured Information About Important Health 
Factors in Pharmacoepidemiology Studies that Rely on Electronic 
Healthcare Databases to Evaluate the Safety of Regulated Pharmaceutical 
Products in the Postapproval Setting'' is corrected to read 
``Inadequate Information on Important Health Factors in 
Pharmacoepidemiology Studies Relying on Healthcare Databases.''

    Dated: April 23, 2015.
Peter Lurie,
Associate Commissioner for Public Health Strategy and Analysis.
[FR Doc. 2015-09966 Filed 4-28-15; 8:45 am]
 BILLING CODE 4164-01-P



                                                                               Federal Register / Vol. 80, No. 82 / Wednesday, April 29, 2015 / Notices                                         23803

                                                  II. Comments                                            Workshop’’ that appeared in the Federal               notice. This notice solicits comments on
                                                     Interested persons may submit either                 Register of April 17, 2015 (80 FR                     information collection on financial
                                                  electronic comments regarding this                      21248). The document announced a                      disclosure by clinical investigators.
                                                  document to http://www.regulations.gov                  public workshop. The document was                     DATES: Submit either electronic or
                                                  or written comments to the Division of                  published with the incorrect title. This              written comments on the collection of
                                                  Dockets Management (see ADDRESSES). It                  document corrects that error.                         information by June 29, 2015.
                                                  is only necessary to send one set of                    FOR FURTHER INFORMATION CONTACT:                      ADDRESSES: Submit electronic
                                                  comments. Identify comments with the                    Leslie Wheelock, Office of the                        comments on the collection of
                                                  docket number found in brackets in the                  Commissioner, Food and Drug                           information to http://
                                                  heading of this document. Received                      Administration, 10903 New Hampshire                   www.regulations.gov. Submit written
                                                  comments may be seen in the Division                    Ave., Bldg. 1, Rm. 4345, Silver Spring,               comments on the collection of
                                                  of Dockets Management between 9 a.m.                    MD, 301–796–8450, FAX: 301–847–                       information to the Division of Dockets
                                                  and 4 p.m., Monday through Friday, and                  8106, leslie.wheelock@fda.hhs.gov.                    Management (HFA–305), Food and Drug
                                                  will be posted to the docket at http://                 SUPPLEMENTARY INFORMATION: In the                     Administration, 5630 Fishers Lane, rm.
                                                  www.regulations.gov.                                    Federal Register of April 17, 2015, in                1061, Rockville, MD 20852. All
                                                                                                          FR Doc. 2015–08846, on page 21248 the                 comments should be identified with the
                                                  III. The Paperwork Reduction Act of                     following correction(s) is/are made:                  docket number found in brackets in the
                                                  1995                                                      1. On page 21248, in the second                     heading of this document.
                                                    This draft guidance refers to                         column, starting at the sixth sentence of             FOR FURTHER INFORMATION CONTACT: FDA
                                                  previously approved collections of                      the first paragraph, the title                        PRA Staff, Office of Operations, Food
                                                  information that are subject to review by               ‘‘Methodological Considerations to                    and Drug Administration, 8455
                                                  the Office of Management and Budget                     Address Unmeasured Information                        Colesville Rd., COLE–14526, Silver
                                                  (OMB) under the Paperwork Reduction                     About Important Health Factors in                     Spring, MD 20993–0002, PRAStaff@
                                                  Act of 1995 (44 U.S.C. 3501–3520). The                  Pharmacoepidemiology Studies that                     fda.hhs.gov.
                                                  collections of information in part 25                   Rely on Electronic Healthcare Databases               SUPPLEMENTARY INFORMATION: Under the
                                                  have been approved under OMB control                    to Evaluate the Safety of Regulated                   PRA (44 U.S.C. 3501–3520), Federal
                                                  number 0910–0322 and the collections                    Pharmaceutical Products in the                        Agencies must obtain approval from the
                                                  of information in part 314 have been                    Postapproval Setting’’ is corrected to                Office of Management and Budget
                                                  approved under OMB control number                       read ‘‘Inadequate Information on                      (OMB) for each collection of
                                                  0910–0001.                                              Important Health Factors in                           information they conduct or sponsor.
                                                                                                          Pharmacoepidemiology Studies Relying                  ‘‘Collection of information’’ is defined
                                                  IV. Electronic Access
                                                                                                          on Healthcare Databases.’’                            in 44 U.S.C. 3502(3) and 5 CFR
                                                    Persons with access to the Internet                     Dated: April 23, 2015.                              1320.3(c) and includes Agency requests
                                                  may obtain the document at either                                                                             or requirements that members of the
                                                                                                          Peter Lurie,
                                                  http://www.fda.gov/Drugs/Guidance                                                                             public submit reports, keep records, or
                                                                                                          Associate Commissioner for Public Health
                                                  ComplianceRegulatoryInformation/                                                                              provide information to a third party.
                                                                                                          Strategy and Analysis.
                                                  Guidances/default.htm or http://                                                                              Section 3506(c)(2)(A) of the PRA (44
                                                                                                          [FR Doc. 2015–09966 Filed 4–28–15; 8:45 am]
                                                  www.regulations.gov.                                                                                          U.S.C. 3506(c)(2)(A)) requires Federal
                                                                                                          BILLING CODE 4164–01–P
                                                    Dated: April 23, 2015.                                                                                      Agencies to provide a 60-day notice in
                                                  Peter Lurie,                                                                                                  the Federal Register concerning each
                                                  Associate Commissioner for Public Health                DEPARTMENT OF HEALTH AND                              proposed collection of information,
                                                  Strategy and Analysis.                                  HUMAN SERVICES                                        including each proposed extension of an
                                                  [FR Doc. 2015–09869 Filed 4–28–15; 8:45 am]
                                                                                                                                                                existing collection of information,
                                                                                                          Food and Drug Administration                          before submitting the collection to OMB
                                                  BILLING CODE 4164–01–P
                                                                                                                                                                for approval. To comply with this
                                                                                                          [Docket No. FDA–2012–N–0280]                          requirement, FDA is publishing notice
                                                  DEPARTMENT OF HEALTH AND                                                                                      of the proposed collection of
                                                                                                          Agency Information Collection
                                                  HUMAN SERVICES                                                                                                information set forth in this document.
                                                                                                          Activities; Proposed Collection;                         With respect to the following
                                                                                                          Comment Request; Financial                            collection of information, FDA invites
                                                  Food and Drug Administration                            Disclosure by Clinical Investigators                  comments on these topics: (1) Whether
                                                  [Docket No. FDA–2015–N–0001]                                                                                  the proposed collection of information
                                                                                                          AGENCY:    Food and Drug Administration,
                                                                                                          HHS.                                                  is necessary for the proper performance
                                                  Addressing Inadequate Information on
                                                                                                          ACTION:   Notice.                                     of FDA’s functions, including whether
                                                  Important Health Factors in
                                                                                                                                                                the information will have practical
                                                  Pharmacoepidemiology Studies
                                                                                                          SUMMARY:  The Food and Drug                           utility; (2) the accuracy of FDA’s
                                                  Relying on Healthcare Databases;
                                                                                                          Administration (FDA) is announcing an                 estimate of the burden of the proposed
                                                  Public Workshop; Correction
                                                                                                          opportunity for public comment on the                 collection of information, including the
                                                  AGENCY:    Food and Drug Administration,                proposed collection of certain                        validity of the methodology and
                                                  HHS.                                                    information by the Agency. Under the                  assumptions used; (3) ways to enhance
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  ACTION:   Notice; correction.                           Paperwork Reduction Act of 1995 (the                  the quality, utility, and clarity of the
                                                                                                          PRA), Federal Agencies are required to                information to be collected; and (4)
                                                  SUMMARY:   The Food and Drug                            publish notice in the Federal Register                ways to minimize the burden of the
                                                  Administration is correcting a notice                   concerning each proposed collection of                collection of information on
                                                  entitled ‘‘Addressing Inadequate                        information, including each proposed                  respondents, including through the use
                                                  Information on Important Health Factors                 extension of an existing collection of                of automated collection techniques,
                                                  in Pharmacoepidemiology Studies                         information, and to allow 60 days for                 when appropriate, and other forms of
                                                  Relying on Healthcare Databases; Public                 public comment in response to the                     information technology.


                                             VerDate Sep<11>2014   17:18 Apr 28, 2015   Jkt 235001   PO 00000   Frm 00043   Fmt 4703   Sfmt 4703   E:\FR\FM\29APN1.SGM   29APN1



Document Created: 2015-12-16 08:25:51
Document Modified: 2015-12-16 08:25:51
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; correction.
ContactLeslie Wheelock, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 4345, Silver Spring, MD, 301-796-8450, FAX: 301-847-8106, [email protected]
FR Citation80 FR 23803 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR